AI in Medicine News — 2026-10-26 (Mon)

Overview

Diagnosis drew the most coverage: several outlets reported a Microsoft AI diagnostic tool outperforming doctors in a study (Futurism, WION, IndexBox, DongA Science). Documentation and operations followed, with ambient AI and hospital AI financing (RamaOnHealthcare, Portal ERP). In drug discovery, OpenAI's acquisition of Orchestra Bio and US curbs on Chinese AI and biotech investment were reported (The Daily Star, Seoul Economic Daily). No device approval or guidance items appeared. Safety and the doctor-AI relationship were covered in a few items (RamaOnHealthcare, Bioengineer.org).

Diagnosis and imaging

- Microsoft says its new AI is better at diagnosing patients than real doctors, per a headline that reads "Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors" (Futurism). Other outlets say it is "Twice as Accurate as Doctors in Study" (IndexBox), diagnoses complex medical cases "more than twice as accurately as doctors, study finds" (WION), and outperforms doctors in accuracy (DongA Science). Evidence stage: a reported study; the headlines give no design, case set or approval status. - An AI approach to oral cancer diagnosis, from clinical imaging to precision therapy, was reported (Bioengineer.org). Evidence stage: not stated. - A UAE medical AI tool from Qritive "Spots 9 in 10 Cases" (shattered.io). The headline does not say what is detected or how this was validated.

Clinical decision support

- Machine learning using patients' own words sharpens emergency triage classification (Bioengineer.org). Evidence stage: not stated. - An explainable AI framework that blends calibrated models predicts heart disease risk (Bioengineer.org). Evidence stage: not stated. 【Generative AI and medical documentation】 - Jefferson Health's ambient AI users closed charts up to 39% faster (RamaOnHealthcare). The headline does not say how this was measured. - Healthleap raised $38 million to expand hospital AI screening (Portal ERP). - eClinicalWorks projects $1.3 billion revenue for 2026 on AI adoption (scanx.trade). 【Hospital operations and care delivery】 - Newsweek covers "The World's Smartest Hospitals, Plus Epic's Next Agentic AI Move" (Newsweek). - A Yahoo Finance Singapore piece covers ImExHS and 2 other Australian AI healthcare stocks, and a Yahoo Finance piece covers Palantir Technologies' sovereign AI push. Both are investor-oriented and are noted here only as coverage (Yahoo Finance Singapore, Yahoo Finance). 【Drug discovery and clinical trials】 - OpenAI acquires biotech startup Orchestra Bio (The Daily Star). The headline gives no development stage. - The US tightens curbs on Chinese investment in AI and biotech (Seoul Economic Daily). - A piece argues pharma leaders should embed AI into business goals (Drug Discovery News). - Funding roundups cover large AI financings (Crunchbase News). Another reports that Flapping Airplanes raised $1B with no product yet, as AI megarounds spread across sectors (Wowtale). Neither headline ties these rounds to drug development. - No headline specifies a preclinical or clinical phase. 【Medical device approvals and regulation】 No notable developments.

Safety, errors and bias

- A piece asks whether Osler's principles are lost in translation in medical AI (Bioengineer.org). - Google's health AI agent "tops Gemini but carries safety gaps," in a 7-point explainer (RamaOnHealthcare). The headline does not specify the gaps. 【Research findings (major journals)】 The headlines do not name the journals or the study designs. - "Doctors and AI: what 271 million clinical questions revealed" (Around Prague). - MedPage Today lists three topics: clinician AI use, predicting bad infant outcomes in labor, and donor heart distribution. - Jabil's 2026 digital health survey found confidence in AI's potential rising while confidence in internal readiness falls (R&D World). - An AI that reads a face can now estimate how long a person has to live (WION). - A research report examines AI-generated high-intensity interval training information (Bioengineer.org).

Developments in Japan

- Okayama University Hospital installed in-house developed digital signage that automatically guides patients to consultation and test locations (Sanyo Shimbun). - A US research team developed an AI model that can estimate the life expectancy of cancer patients from a face photo alone (CNN.co.jp). Evidence stage: model development; validation is not stated in the headline. - Chinese internet giants Ant, JD.com and ByteDance are entering "AI doctor" services one after another, and their business models are still being worked out (Toyo Keizai). - A weekly topics list includes the theme of developing a medical artificial intelligence system (Fisco via Yahoo! Finance). - A Vietnam.vn piece says AI supports better decision-making but does not replace doctors (Vietnam.vn).

Statements by key figures

No notable developments.